Integrated bioinformatics analysis reveals that OPRK1 inhibits ferroptosis and induces enzalutamide resistance in prostate cancer
Abstract Enzalutamide (Enz) is employed in the management of castration-resistant prostate cancer (CRPC). However, a substantial subset of patients may develop resistance to Enz, thereby reducing its therapeutic effectiveness. The underlying mechanisms contributing to the development of Enz resistan...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-04-01
|
| Seri Bilgileri: | European Journal of Medical Research |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s40001-025-02484-9 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|